A Peptide-Based Checkpoint Immunomodulator Alleviates Immune Dysfunction in Murine Polymicrobial Sepsis
Timothy W. Phares(Leidos (United States)), Gabriel M. Gutierrez(Leidos (United States)), Vinayaka Kotraiah(Leidos (United States)), Jacqueline Unsinger(Washington University in St. Louis), James Pannucci(Leidos (United States)), Peter Buontempo, Richard S. Hotchkiss(Washington University in St. Louis), Cecille D. Browne, Kenneth E. Remy(Washington University in St. Louis), Monty B. Mazer(Rainbow Babies & Children's Hospital), Marc Mansour(Leidos (United States)), Chun‐Shiang Chung(Brown University), Alfred Ayala(Brown University)
Cited by 20
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Sepsis and septic shock
|Nature Reviews Disease Primers|2016|1.6k
MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis
|The Journal of Experimental Medicine|2007|647
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
|JCI Insight|2018|412
Immunotherapy for Sepsis — A New Approach against an Ancient Foe
|New England Journal of Medicine|2010|367